Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr Hoenle Aktiengesellschaft Issues FY 2011/2012 Revenue and Operating Result Guidance In Line with Analysts' Estimates


Thursday, 23 Aug 2012 07:24pm EDT 

Dr Hoenle Aktiengesellschaft announced that its Management Board aims at achieving sales revenues of more than EUR 70 million and an operating result of EUR 8 million for the fiscal year 2011/2012. According to I/B/E/S Estimates, analysts on average are expecting the Company to report fiscal year 2011/2012 revenue of EUR 74.50 million and EBIT of EUR 7.80 million. 

Company Quote

16.22
-0.015 -0.09%
23 Jul 2014